PATENT CLAIM ANALYSIS

Application Number: 15742874
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["530", "387300"]

Abstract:
The present invention relates to the preparation of an antibody analogue capable of being activated reversibly, and uses thereof, and provides a fusion protein comprising an inactive first fragment of an antibody analogue is fused to a stimulus-induced dimerization protein.

Claim (Index 23):
The fusion protein of  claim 4 , wherein the stimulus-induced dimerization partner protein is a light-induced dimerization partner protein or ligand-induced dimerization partner protein.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.34375
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10226949', '15311198', '14004879', '15190337', '15618770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6948119082193137
- 35 USC 102 Novelty (BERT): 0.5004996758760087
- Combined Prediction Score: 0.6753806849849832
- Mean Citation Score: 262.46429
- Max Citation Score: 274.88907
- Similarity Product: 219.82574770836712

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test